Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Efficacy of Systemic Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Locally Inoperable Progressive Soft Tissue Metastases

NCT00264056 is registered in ClinicalTrials.gov with Fachklinik Hornheide an der Universität Münster as lead sponsor.

NCT NCT00264056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00264056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Efficacy of Systemic Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Locally Inoperable Progressive Soft Tissue Metastases
Lead sponsor
Fachklinik Hornheide an der Universität Münster
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2005
Completion date
June 30, 2007
Enrollment
26
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced metastastic malignant melanoma, refractory to first-line chemotherapy irresectable progressive soft tissue metastases